Ribero, D., Wang, H., Donadon, M., Zorzi, D., Thomas, M. B., Eng, C., . . . Vauthey, N. (2007). Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Ribero, David, et al. Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases. 2007.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Ribero, David, et al. Bevacizumab Improves Pathologic Response and Protects Against Hepatic Injury in Patients Treated With Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases. 2007.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.